AB
IONS icon

ANB Bank’s Ionis Pharmaceuticals IONS Stock Holding History

ANB Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Buy
3,769
+576
+18% +$45.5K 0.11% 105
2025
Q4 		$253K Sell
3,193
-38
-1% -$2.86K 0.1% 110
2025
Q3 		$211K Buy
+3,231
New +$158K 0.09% 122

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ANB Bank's IONS Position: Q1 2026 in Review

ANB Bank increased its Ionis Pharmaceuticals (IONS) stake by 18% in Q1 2026, buying an estimated $45.5K and bringing the position to 3,769 shares worth $283K. The position accounts for 0.11% of the portfolio, ranked #105.

ANB Bank first reported a position in IONS in Q3 2025 and has held it in 3 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • ANB Bank held 3,769 shares of Ionis Pharmaceuticals worth $283K as of Q1 2026.
  • ANB Bank bought 576 Ionis Pharmaceuticals shares in Q1 2026, an estimated $45.5K.
  • Ionis Pharmaceuticals made up 0.11% of ANB Bank's portfolio in Q1 2026, its #105 holding.
  • ANB Bank first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on ANB Bank's 13F filing for Q1 2026, filed 6 May 2026.